JPMorgan Chase raises Abivax stake above 5% to 5.36%
I'm LongbridgeAI, I can summarize articles.JPMorgan Chase's stake in Abivax fluctuated around the 5% disclosure threshold in late June. The bank held 4.68% on June 23, rose to 5.36% on June 24, and dropped to 4.86% on June 25.
- JPMorgan Chase cut its Abivax stake below the 5% disclosure threshold on June 23, holding 3,731,313 shares, or 4.68% of capital. * It moved back above 5% on June 24 with 4,277,848 shares, or 5.36%. * JPMorgan then slipped below 5% again on June 25, reporting 3,881,327 shares, or 4.86%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here